相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Influence of Biologic Subtype of Inflammatory Breast Cancer on Response to Neoadjuvant Therapy and Cancer Outcomes
Tina J. Hieken et al.
CLINICAL BREAST CANCER (2018)
Inflammatory breast cancer: The pathologists' perspective
G. Cserni et al.
EJSO (2018)
International Consensus on the Clinical Management of Inflammatory Breast Cancer from the Morgan Welch Inflammatory Breast Cancer Research Program 10th Anniversary Conference
Naoto T. Ueno et al.
JOURNAL OF CANCER (2018)
Chemotherapy response and survival of inflammatory breast cancer by hormone receptor- and HER2-defined molecular subtypes approximation: an analysis from the National Cancer Database
Jieqiong Liu et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2017)
The Impact of Residual Disease After Preoperative Systemic Therapy on Clinical Outcomes in Patients with Inflammatory Breast Cancer
Faina Nakhlis et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
Inflammatory breast cancer in the Netherlands; improved survival over the last decades
D. J. P. van Uden et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Comparison of SEER Treatment Data With Medicare Claims
Anne-Michelle Noone et al.
MEDICAL CARE (2016)
Outcomes After Multidisciplinary Treatment of Inflammatory Breast Cancer in the Era of Neoadjuvant HER2-directed Therapy
Chiaojung Jillian Tsai et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2015)
Inflammatory Breast Cancer: Patterns of Failure and the Case for Aggressive Locoregional Management
Laura E. G. Warren et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Initial Response to Chemotherapy, Not Delay in Diagnosis, Predicts Overall Survival in Inflammatory Breast Cancer Cases
Heather J. Hoffman et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2014)
Long-term treatment efficacy in primary inflammatory breast cancer by hormonal receptor- and HER2-defined subtypes
H. Masuda et al.
ANNALS OF ONCOLOGY (2014)
Primary tumor resection as a component of multimodality treatment may improve local control and survival in patients with stage IV inflammatory breast cancer
Catherine L. Akay et al.
CANCER (2014)
Underuse of Trimodality Treatment Affects Survival for Patients With Inflammatory Breast Cancer: An Analysis of Treatment and Survival Trends From the National Cancer Database
Natasha M. Rueth et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
US Incidence of Breast Cancer Subtypes Defined by Joint Hormone Receptor and HER2 Status
Nadia Howlader et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Management of inflammatory breast cancer: Focus on radiotherapy with an evidence-based approach
Vieri Scotti et al.
CANCER TREATMENT REVIEWS (2013)
Risk Factors for Locoregional Failure in Patients With Inflammatory Breast Cancer Treated With Trimodality Therapy
Kunal Saigal et al.
CLINICAL BREAST CANCER (2013)
Predictive value of breast cancer molecular subtypes in Chinese patients with four or more positive nodes after postmastectomy radiotherapy
San-Gang Wu et al.
BREAST (2012)
Characteristics and outcomes according to molecular subtypes of breast cancer as classified by a panel of four biomarkers using immunohistochemistry
Seho Park et al.
BREAST (2012)
Underascertainment of radiotherapy receipt in Surveillance, Epidemiology, and End Results registry data
Reshma Jagsi et al.
CANCER (2012)
International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment
S. Dawood et al.
ANNALS OF ONCOLOGY (2011)
Triple-Negative Subtype Predicts Poor Overall Survival and High Locoregional Relapse in Inflammatory Breast Cancer
Jing Li et al.
ONCOLOGIST (2011)
GPR30 and estrogen receptor expression: new insights into hormone dependence of inflammatory breast cancer
Hugo Arias-Pulido et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Inflammatory Breast Cancer The Disease, the Biology, the Treatment
Fredika M. Robertson et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Inflammatory Breast Cancer-The Royal Marsden Hospital Experience A Review of 155 Patients Treated From 1990 to 2007
Stephanie Sutherland et al.
CANCER (2010)
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Joel S. Parker et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Prognostic impact of human epidermal growth factor-like receptor 2 and hormone receptor status in inflammatory breast cancer (IBC): analysis of 2,014 IBC patient cases from the California Cancer Registry
Jason A. Zell et al.
BREAST CANCER RESEARCH (2009)
Prognostic significance of HER-2 status in women with inflammatory breast cancer
Shaheenah Dawood et al.
CANCER (2008)
The triple negative paradox: Primary tumor chemosensitivity of breast cancer subtypes
Lisa A. Carey et al.
CLINICAL CANCER RESEARCH (2007)
Trends for inflammatory breast cancer: Is survival improving?
Ana M. Gonzalez-Angulo et al.
ONCOLOGIST (2007)
Trends in inflammatory breast carcinoma incidence and survival: The Surveillance, Epidemiology, and End Results Program at the National Cancer Institute
KW Hance et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Inflammatory breast carcinoma: Outcomes with trimodality therapy for nonmetastatic disease
SL Liauw et al.
CANCER (2004)
分享论文
